The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation.
Sung WJ, Kim D, Zhu A, Cho N, Yoo HM, Noh JH, Kim KM, Lee HS, Hong J.
Sung WJ, et al. Among authors: kim km, kim d.
Front Pharmacol. 2022 Nov 11;13:1050758. doi: 10.3389/fphar.2022.1050758. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36438839
Free PMC article.
Review.